ERAD Therapeutics Inc.

Addressing ~30 Rare Diseases; Experienced management team; Excellent Proof of Concept data; Pre-clinical, entering manufacturing; Early exit strategies.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Toronto, ON, Canada
  • Currency CAD
  • Founded 2014
  • Employees 3

Company Summary

A pre-clinical stage biotechnology company founded in partnership with the Hospital for Sick Children.
Developing a proprietary therapeutic technology to address 30+ Orphan/Rare Diseases (cystic fibrosis, Gaucher's Disease, Niemann-Pick Type C1, many others) resulting from genetic mutations in key proteins in the cell.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free